Nearly 10 years after the first JAK inhibitor was approved for a dermatologic disorder, more uses are imminent, with fewer safety concerns.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/dermatology-emerging-data-support-relative-safety-jak-2025a10010mv?src=rss
Author :
Publish date : 2025-12-30 05:04:00
Copyright for syndicated content belongs to the linked Source.